StockData
Protagenic Therapeutics, Inc.new logo

Protagenic Therapeutics, Inc.new (PTIX) stock

PTIXOTCPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026
$0.75+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.36MP/E –Yield –

Earnings

Protagenic Therapeutics, Inc.new's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Protagenic Therapeutics, Inc.new's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Protagenic Therapeutics, Inc.new has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Protagenic Therapeutics, Inc.new puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Protagenic Therapeutics, Inc.new filed with the SEC as exhibits to Form 8-K or 6-K

See a number that looks wrong?